Armistice Capital »

Marvell Technology shares owned by Armistice Capital

Quarter-by-quarter ownership of Marvell Technology (MRVL) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Marvell Technology

Tip: Access up to 7 years of quarterly data

All positions including Marvell Technology held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marvell Technology by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 19k 84.07

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Marvell Technology

FMR
Vanguard Group
BlackRock
Susquehanna International
Jane Street
State Street Corporation
Citadel Advisors
UBS Group
Ameriprise Financial
Fil
Goldman Sachs Group
Geode Capital Management
Franklin Resources
Brown Advisory Holdings Incorporated
Invesco

View all funds holding Marvell Technology